These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 9036610)

  • 21. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.
    Stamey TA; Johnstone IM; McNeal JE; Lu AY; Yemoto CM
    J Urol; 2002 Jan; 167(1):103-11. PubMed ID: 11743285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate tissue and serum markers.
    Mazzucchelli R; Colanzi P; Pomante R; Muzzonigro G; Montironi R
    Adv Clin Path; 2000 Jul; 4(3):111-20. PubMed ID: 11080790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative value of molecular forms of prostate-specific antigen in diagnosis of prostatic cancer].
    Mazo EB; Sergeeva NA; Grigor'ev ME; Lebedev DV; Solov'eva EV; Konorev VA; Krovets AA
    Urologiia; 2006; (3):21-4. PubMed ID: 16889084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The usefulness of serum human kallikrein 11 for discriminating between prostate cancer and benign prostatic hyperplasia.
    Nakamura T; Scorilas A; Stephan C; Jung K; Soosaipillai AR; Diamandis EP
    Cancer Res; 2003 Oct; 63(19):6543-6. PubMed ID: 14559849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate.
    Jung K; Meyer A; Lein M; Rudolph B; Schnorr D; Loening SA
    J Urol; 1998 May; 159(5):1595-8. PubMed ID: 9554361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Differential diagnostic value of prostate-specific antigen in prostatic hyperplasia].
    Maksimov VA; Kamalov AA; Karpov VK; Riaboĭ AV; Prokhorov AV
    Urologiia; 2001; (2):37-40. PubMed ID: 11490716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Parameters of PSA fractions in early diagnosis of prostatic cancer in healthy males over 50].
    Loran OB; Krokhotina LV; Pushkar' DIu; Valiev AZ; Rasner PI
    Urol Nefrol (Mosk); 1999; (1):19-21. PubMed ID: 11149339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of prostatic massage on serum complexed prostate-specific antigen levels.
    Tarhan F; Orçun A; Küçükercan I; Camursoy N; Kuyumcuoğlu U
    Urology; 2005 Dec; 66(6):1234-8. PubMed ID: 16360449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum-to-urinary prostate-specific antigen ratio in patients with benign prostatic hyperplasia and prostate cancer.
    Hillenbrand M; Bastian M; Steiner M; Zingler C; Müller M; Wolff JM; Seiter H; Schuff-Werner P
    Anticancer Res; 2000; 20(6D):4995-6. PubMed ID: 11326656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Free and total serum PSA values in patients with prostatic intraepithelial neoplasia (PIN), prostate cancer and BPH. Is F/T PSA a potential probe for dormant and manifest cancer?
    Tarle M; Kraljić I
    Anticancer Res; 1997; 17(3A):1531-4. PubMed ID: 9179191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variation of free and total prostate-specific antigen levels: the effect on the percent free/total prostate-specific antigen.
    Nixon RG; Lilly JD; Liedtke RJ; Batjer JD
    Arch Pathol Lab Med; 1997 Apr; 121(4):385-91. PubMed ID: 9140308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PSA excess in the differential diagnosis of prostate carcinoma.
    Díaz F; Morell M; Rojo G
    Arch Esp Urol; 1997 May; 50(4):415-8. PubMed ID: 9219422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of the complex between prostate specific antigen and alpha 1-protease inhibitor for screening prostate cancer.
    Finne P; Zhang WM; Auvinen A; Leinonen J; Määttänen L; Rannikko S; Tammela TL; Stenman UH
    J Urol; 2000 Dec; 164(6):1956-60. PubMed ID: 11061890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three new serum markers for prostate cancer detection within a percent free PSA-based artificial neural network.
    Stephan C; Xu C; Brown DA; Breit SN; Michael A; Nakamura T; Diamandis EP; Meyer H; Cammann H; Jung K
    Prostate; 2006 May; 66(6):651-9. PubMed ID: 16388506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Protein of type 1 binding insulin-like growth factors in blood serum in cancer and prostatic adenoma].
    Morozov AP; Trapeznikov MF; Kushlinskiĭ NE
    Urologiia; 2007; (2):50-3. PubMed ID: 17580387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production of serum-free and total prostate-specific antigen due to prostatic intraepithelial neoplasia.
    Minardi D; Galosi AB; Dell'Atti L; Hanitzsch H; Mario P; Muzzonigro G
    Scand J Urol Nephrol; 2002; 36(5):323-9. PubMed ID: 12487735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IGF-II serum levels increase discrimination between benign prostatic hyperplasia and prostate cancer and improve the predictive value of PSA in clinical staging.
    Trojan L; Bode C; Weiss C; Mayer D; Grobholz R; Alken P; Michel MS
    Eur Urol; 2006 Feb; 49(2):286-92; discussion 292. PubMed ID: 16386354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical significance of prostate specific antigen and gamma-seminoprotein ratio for diagnosing prostate cancer].
    Akino H; Suzuki Y; Okada K
    Nihon Rinsho; 1998 Aug; 56(8):2003-5. PubMed ID: 9750496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The significance of free-type PSA and complex-type PSA in patients with prostatic carcinoma--the characteristics of ACS-PSA method compared with that of Delfia- and Eiken-PSA method].
    Arai K; Honda M; Hosoya Y; Sumi S; Umeda H; Yoshida K
    Rinsho Byori; 1996 Apr; 44(4):345-50. PubMed ID: 8847816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical usefulness of the new criteria based on the serum quantification of prostate-specific antigen in the early diagnosis of prostatic cancer].
    Morote Robles J
    Actas Urol Esp; 1996 Jan; 20(1):1-12. PubMed ID: 8720993
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.